Patent details

300914 Product Name: Atezolizumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300914
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2376535
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
300914
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)

Marketing Authorization

Marketing Authorization Number:
EU/1/17/1220
Marketing Authorization Type:
EEA
Marketing Authorization Date:
25/09/2017
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
29/11/2017
First Marketing Authorization date:
25/09/2017
Grant date:
01/02/2018
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
04/12/2017
SPC/SPC Extension Expiration Date:
24/09/2032
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
29/11/2017
 
 

 

Name:
F.Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 BASEL, Switzerland (CH)

Agent

Name:
ir. H.A. Witmans c.s.
From:
29/11/2017
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
20/23
Publication date:
17/05/2023
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
07/18
Publication date:
07/02/2018
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
49/17
Publication date:
06/12/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/12/2029
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
01/02/2018 Outgoing Correspondence Outgoing Letter 1 PDF /5/3/7/9/1/0800219735/docs/300914_0_outgoingcorrespondence20180202095938784.pdf
01/02/2018 SPC Documents Certificate SPC 1 PDF /5/3/7/9/1/0800219735/docs/300914_3_supplprotectioncertificate20180202095938859.pdf
06/12/2017 Outgoing Correspondence Confirmation receipt request 1 PDF /5/3/7/9/1/0800219735/docs/300914_10_178760l174.pdf
30/11/2017 SPC Documents Annex SPC 4 PDF /5/3/7/9/1/0800219735/docs/300914_1_supplprotectioncertificate20171204030537299.pdf
30/11/2017 SPC Documents Annex SPC 1 PDF /5/3/7/9/1/0800219735/docs/300914_2_supplprotectioncertificate20210113040746362.pdf
30/11/2017 Application Form First filed application form 3 PDF /5/3/7/9/1/0800219735/docs/300914_4_applicationform20171204030536832.pdf
30/11/2017 SPC Documents Annex SPC 14 PDF /5/3/7/9/1/0800219735/docs/300914_5_supplprotectioncertificate20171204030537385.pdf
30/11/2017 SPC Documents Summary of the characteristics of the product 27 PDF /5/3/7/9/1/0800219735/docs/300914_6_supplprotectioncertificate20171204030537208.pdf
30/11/2017 SPC Documents Marketing Authorization SPC 3 PDF /5/3/7/9/1/0800219735/docs/300914_7_supplprotectioncertificate20171204030537119.pdf
30/11/2017 SPC Documents Annex SPC 1 PDF /5/3/7/9/1/0800219735/docs/300914_8_supplprotectioncertificate20210113040606827.pdf
30/11/2017 SPC Documents Accompanying letter SPC 1 PDF /5/3/7/9/1/0800219735/docs/300914_9_supplprotectioncertificate20171204030537484.pdf